Doris Clark-ackun
Examiner (ID: 7457)
Most Active Art Unit | 2914 |
Art Unit(s) | 2914, CSD, 2899, 2915, 2900, 2901, 2904 |
Total Applications | 8203 |
Issued Applications | 8097 |
Pending Applications | 0 |
Abandoned Applications | 105 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7674620
[patent_doc_number] => 20040127498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Heterocyclic side chain containing, n-substituted metalloprotease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/758791
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17227
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10758791
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/758791 | Heterocyclic side chain containing, n-substituted metalloprotease inhibitors | Jan 15, 2004 | Abandoned |
Array
(
[id] => 655343
[patent_doc_number] => 07109355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Fluorinated π-bridge second order nonlinear optical chromophores and electro-optic devices therefrom'
[patent_app_type] => utility
[patent_app_number] => 10/757375
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5356
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10757375
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/757375 | Fluorinated π-bridge second order nonlinear optical chromophores and electro-optic devices therefrom | Jan 13, 2004 | Issued |
Array
(
[id] => 616505
[patent_doc_number] => 07144917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'Inhibitors of matrix metalloproteinases'
[patent_app_type] => utility
[patent_app_number] => 10/746812
[patent_app_country] => US
[patent_app_date] => 2003-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14708
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/144/07144917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10746812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/746812 | Inhibitors of matrix metalloproteinases | Dec 23, 2003 | Issued |
Array
(
[id] => 7411267
[patent_doc_number] => 20040176438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake'
[patent_app_type] => new
[patent_app_number] => 10/743404
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118170
[patent_no_of_claims] => 150
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10743404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/743404 | Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake | Dec 22, 2003 | Abandoned |
Array
(
[id] => 7347432
[patent_doc_number] => 20040192740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto'
[patent_app_type] => new
[patent_app_number] => 10/741595
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9591
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741595
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741595 | Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto | Dec 18, 2003 | Issued |
Array
(
[id] => 7446890
[patent_doc_number] => 20040186060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Matriptase inhibitors and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/740946
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19112
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10740946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/740946 | Matriptase inhibitors and methods of use | Dec 17, 2003 | Issued |
Array
(
[id] => 7288036
[patent_doc_number] => 20040147454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Aspartyl protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/731922
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32152
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147454.pdf
[firstpage_image] =>[orig_patent_app_number] => 10731922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/731922 | Aspartyl protease inhibitors | Dec 9, 2003 | Issued |
Array
(
[id] => 397754
[patent_doc_number] => 07294723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Multifunctional cationic photoinitiators, their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 10/538243
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15099
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538243 | Multifunctional cationic photoinitiators, their preparation and use | Dec 9, 2003 | Issued |
Array
(
[id] => 7674586
[patent_doc_number] => 20040127532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Method for synthesizing leflunomide'
[patent_app_type] => new
[patent_app_number] => 10/730949
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4471
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10730949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/730949 | Method for synthesizing leflunomide | Dec 9, 2003 | Abandoned |
Array
(
[id] => 7607475
[patent_doc_number] => 07098241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'Thiophene hydroxamic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/732633
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12703
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098241.pdf
[firstpage_image] =>[orig_patent_app_number] => 10732633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/732633 | Thiophene hydroxamic acid derivatives | Dec 9, 2003 | Issued |
Array
(
[id] => 663753
[patent_doc_number] => 07102016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-05
[patent_title] => 'Preparation of 2,2′-di(3,4-ethylenedioxythiophene)s'
[patent_app_type] => utility
[patent_app_number] => 10/727736
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5366
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/102/07102016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727736 | Preparation of 2,2′-di(3,4-ethylenedioxythiophene)s | Dec 3, 2003 | Issued |
Array
(
[id] => 724855
[patent_doc_number] => 07045551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => '1-aryl-2-hydroxyethyl amides as potassium channel openers'
[patent_app_type] => utility
[patent_app_number] => 10/719465
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13735
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719465
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719465 | 1-aryl-2-hydroxyethyl amides as potassium channel openers | Nov 20, 2003 | Issued |
Array
(
[id] => 7412041
[patent_doc_number] => 20040106657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Indolyl derivatives'
[patent_app_type] => new
[patent_app_number] => 10/719556
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10278
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719556 | Indolyl derivatives | Nov 20, 2003 | Issued |
Array
(
[id] => 946642
[patent_doc_number] => 06964976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-15
[patent_title] => 'Amino alcohol derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/718858
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116275
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/964/06964976.pdf
[firstpage_image] =>[orig_patent_app_number] => 10718858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/718858 | Amino alcohol derivatives | Nov 19, 2003 | Issued |
Array
(
[id] => 7672837
[patent_doc_number] => 20040180942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Heterocyclic modulators of nuclear receptors'
[patent_app_type] => new
[patent_app_number] => 10/717049
[patent_app_country] => US
[patent_app_date] => 2003-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 72341
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10717049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/717049 | Heterocyclic modulators of nuclear receptors | Nov 17, 2003 | Issued |
Array
(
[id] => 7469995
[patent_doc_number] => 20040102498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Estrogen receptor modulators'
[patent_app_type] => new
[patent_app_number] => 10/713621
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47651
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10713621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/713621 | Estrogen receptor modulators | Nov 12, 2003 | Issued |
Array
(
[id] => 7291499
[patent_doc_number] => 20040110806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Dipeptide derivatives'
[patent_app_type] => new
[patent_app_number] => 10/694672
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27009
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10694672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/694672 | Dipeptide derivatives | Oct 27, 2003 | Abandoned |
Array
(
[id] => 7281592
[patent_doc_number] => 20040063969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Process for the preparation of amorphous atorvastatin calcium'
[patent_app_type] => new
[patent_app_number] => 10/689823
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1788
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10689823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/689823 | Process for the preparation of amorphous atorvastatin calcium | Oct 19, 2003 | Abandoned |
Array
(
[id] => 7470055
[patent_doc_number] => 20040102506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Pyrazole compositions useful as inhibitors of ERK'
[patent_app_type] => new
[patent_app_number] => 10/688613
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15472
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102506.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688613 | Pyrazole compositions useful as inhibitors of erk | Oct 16, 2003 | Issued |
Array
(
[id] => 695473
[patent_doc_number] => 07071215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-04
[patent_title] => 'Anthelmintic and insecticidal compositions'
[patent_app_type] => utility
[patent_app_number] => 10/687496
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10043
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071215.pdf
[firstpage_image] =>[orig_patent_app_number] => 10687496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/687496 | Anthelmintic and insecticidal compositions | Oct 15, 2003 | Issued |